| 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 454,6 k € | +100.6% | 226,6 k € | +736.9% | -35,6 k € | |
| EBITDA | 198,5 k € | +924.3% | 19,4 k € | +123.4% | -82,9 k € | |
| Operating profit | 22,0 k € | +30.4% | 16,9 k € | +120.2% | -83,6 k € | |
| Profit/loss | 22,1 k € | +33.8% | 16,5 k € | +119.7% | -83,6 k € | |
| Equity | 455,0 k € | +5.1% | 432,9 k € | +4.0% | 416,4 k € | |
| Total assets | 692,1 k € | +46.7% | 471,9 k € | -5.6% | 500,0 k € | |
| Cash | 104,6 k € | +29.2% | 80,9 k € | -70.3% | 272,2 k € | |
| Debts | 237,0 k € | +507.2% | 39,0 k € | -15.3% | 46,1 k € | |
Public limited company · Gent · incorporated on 25/02/2022
Public limited company profitable and well capitalised. Cash position rising (+29.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
CELL-CELL BIO is a Public limited company incorporated in 2022. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent.